Applications of Cannabis in Food and Its Potential Perspectives Applications of Cannabis in Food and Its Potential Perspectives

Main Article Content

Sukrichaya Hemathulin
Jarckrit Jeeunngoi


Cannabis is a plant of the hemp family (Cannabinaceae) that has long been used as a food because it is a superfood containing phytonutrients with interesting biological activity. This review article discusses both the positive and negative health effects of cannabis, as well as the legalization of cannabis use in Thailand, including its use in various foods. Cannabis contains a variety of bioactive phytonutrients that are both health beneficial and psychoactive effect. In recent years, many phytonutrients in cannabis have been developed into active ingredients in a wide range of foods, including beverages, confectioneries, bakeries, and other food ingredients. In addition, this review provides scientific research literature on the potential use of cannabis and its derivatives as dietary supplements for possible health benefits and future applications. Thus, the goal of this article is to review the empirical scientific evidence on the use of cannabis in food. The results of this study will serve as a preliminary guide to the application of cannabis in food and its future use.


Download data is not yet available.

Article Details



Addo P.W., Brousseau V.D., Morello V., MacPherson S., Paris M. and Lefsrud M.G. (2021). Cannabis chemistry, post-harvest processing methods and secondary metabolite profiling: A review. Industrial Crops and Products. 170: 113743-113755.

Aluko RE. (2017). Hemp seed (Cannabis sativa L.) proteins: composition, structure, enzymatic modification, and functional or bioactive properties. Sustainable Protein Sources. Cambridge, MA: Academic Press, pp. 121–132.

Andrews K. W., Gusev P. A., McNeal M., Savarala S., Dang P. and Oh L. (2018). Dietary Supplement Ingredient Database (DSID) and the Application of Analytically Based Estimates of Ingredient Amount to Intake Calculations. The Journal of nutrition. 148: 1413S–1421S.

Babson K. A., Sottile J. and Morabito D. (2017). Cannabis, Cannabinoids, and Sleep: A Review of the Literature. Current psychiatry reports. 19(4): 23-35.

Bonini S. A., Premoli M., Tambaro S., Kumar A., Maccarinelli G. and Memo M. (2018). Cannabis sativa: A comprehensive ethnopharmacological review of a medicinal plant with a long history. Journal of ethnopharmacology. 227: 300–315.

Booth J. K., Page J. E. and Bohlmann J. (2017). Terpene synthases from Cannabis sativa. PloS one. 12(3): 1-20.

Brighenti V., Pellati F., Steinbach M., Maran D., and Benvenuti S. (2017). Development of a new extraction technique and HPLC method for the analysis of non-psychoactive cannabinoids in fibre-type Cannabis sativa L. (hemp). Journal of pharmaceutical and biomedical analysis. 143: 228–236.

Carlini E.A. (2004). The good and the bad effects of trans-delta-9-tetrahydrocannabinol on humans. Toxicon. 44: 461-467.

Cerino P., Buonerba C., Cannazza G., D'Auria J., Ottoni E. and Fulgione A. (2021). A Review of Hemp as Food and Nutritional Supplement. Cannabis and cannabinoid research. 6(1): 19–27.

Chandra S., Lata H., Khan I.A. and ElSohly M.A. (2017). Cannabis sativa L.: Botany and Horticulture. In: Chandra, S., Lata, H., ElSohly, M. (eds) Cannabis sativa L. - Botany and Biotechnology. Springer, Cham.

Da Porto C., Decorti D. and Natolino A. (2015). Potential oil yield, fatty acid composition, and oxidation stability of the hempseed oil from four Cannabis sativa L. cultivars. Journal of dietary supplements. 12(1): 1–10.

Del Bo' C., Deon V., Abello F., Massini G., Porrini M., Riso P. and Guardamagna O. (2019). Eight-week hempseed oil intervention improves the fatty acid composition of erythrocyte phospholipids and the omega-3 index but does not affect the lipid profile in children and adolescents with primary hyperlipidemia. Food research international. 119: 469–476.

European Industrial Hemp Association. (2017). Reasonable Guidance Values for THC (Tetrahydrocannabinol) in Food Products. Retrieved June 10, 2022, from /09/17-09-18-THC-Position-paper_EIHA.pdf.

Farag S. and Kayser O. (2017). Handbook of Cannabis and Related Pathologies: Biology, Pharmacology, Diagnosis, and Treatment (2nd Ed.). MA: Elsevier.

Farinon B., Molinari R., Costantini L. and Merendino N. (2020). The seed of industrial hemp (Cannabis sativa L.): Nutritional Quality and Potential Functionality for Human Health and Nutrition. Nutrients. 12(7): 1935-1994.

Food division. (2022). Food and Drug Administration of Thailand. Permission for products containing cannabis, hemp and cannabidiol extracts. Retrieved June 13, 2022, from https://www.fda. /SitePages/cannabis.aspx.

Gertsch J. (2017). Cannabimimetic phytochemicals in the diet - an evolutionary link to food selection and metabolic stress adaptation?. British journal of pharmacology. 174(11): 1464–1483.

Hanus L.O., Meyer S.M., Muñoz E., Taglialatela-Scafati O. and Appendino G., (2016). Phytocannabinoids: a unified critical inventory. Nat. Prod. Rep. 33: 1357–1392.

Hazekamp A. and Fischedick J. T. (2012). Cannabis - from cultivar to chemovar. Drug testing and analysis. 4(7-8): 660–667.

Huestis M. A. (2007). Human cannabinoid pharmacokinetics. Chemistry & biodiversity. 4(8): 1770–1804.

Huestis M. A., Gorelick D. A., Heishman S. J., Preston K. L., Nelson R. A. and Moolchan E. T. (2001). Blockade of effects of smoked marijuana by the CB1-selective cannabinoid receptor antagonist SR141716. Archives of general psychiatry. 58(4): 322–328.

Iftikhar A., Zafar U., Ahmed W., Shabbir M. A., Sameen A. and Sahar A. (2021). Applications of Cannabis Sativa L. in Food and Its Therapeutic Potential: From a Prohibited Drug to a Nutritional Supplement. Molecules. 26(24): 7699-7720.

Jin D., Dai K., Xie Z. and Chen J. (2020). Secondary Metabolites Profiled in Cannabis Inflorescences, Leaves, Stem Barks, and Roots for Medicinal Purposes. Scientific reports. 10(1): 3309-3323.

Kanabus J., Bryła M., Roszko M., Modrzewska M. and Pierzgalski A. (2021). Cannabinoids-Characteristics and Potential for Use in Food Production. Molecules. 26(21): 6723-6759.

Korus J., Witczak M., Ziobro R. and Juszczak L. (2017). Hemp (Cannabis sativa subsp. sativa) flour and protein preparation as natural nutrients and structure forming agents in starch-based gluten-free bread. Lwt - Food Science and Technology. 84: 143-150.

Laohavanich, M. (2022). Political economy of cannabis in Thailand. Chula Med J. 66: 115-122.

Lastres-Becker I., Molina-Holgado F., Ramos J.A., Mechoulam R. and Fernandez-Ruiz J. (2005). Cannabinoids provide neuroprotection against 6-hydroxydopamine toxicity in vivo and in vitro: Relevance to Parkinson’s disease. Neurobiology of Disease. 19: 96-107.

Lowe H., Steele B., Bryant J., Toyang N. and Ngwa, W. (2021). Non-Cannabinoid Metabolites of Cannabis sativa L. with Therapeutic Potential. Plants. 10(2): 400-417.

Lucas C. J., Galettis P. and Schneider J. (2018). The pharmacokinetics and the pharmacodynamics of cannabinoids. British journal of clinical pharmacology. 84(11): 2477–2482.

McPartland J.M. (2017). Cannabis sativa and Cannabis indica versus (2nd ed.). MA: Springer.

Morales P., Hurst D. P. and Reggio P. H. (2017). Molecular Targets of the Phytocannabinoids: A Complex Picture. Progress in the chemistry of organic natural products. 103: 103–131.

Muralidhar Reddy P., Maurya N. and Velmurugan B.K. (2019). Medicinal Use of Synthetic Cannabinoids—a Mini Review. Curr Pharmacol Rep. 5: 1–13.

Oregon Liquor and Cannabis Commission. (2021). Considerations in Establishing Cannabinoid Limits for Hemp Products; Rationale for Rulemaking. Retrieved June 12, 2022, from http:// gov/olcc/Docs /commission_minutes /2021/Considerations-In-Establishing-Cannabinoi d-Limits-Hemp-Whitepaper.pdf.

Pellati F., Borgonetti V., Brighenti V., Biagi M., Benvenuti S. and Corsi L. (2018). Cannabis sativa L. and Nonpsychoactive Cannabinoids: Their Chemistry and Role against Oxidative Stress, Inflammation, and Cancer. BioMed research international. 2018: 1-15.

Prutipinyo, C. (2017). Comparative Drug Control Law. Public Health & Health Laws Journal. 3(2): 148-166.

Radhakrishnan R., Wilkinson S. T., and D'Souza D. C. (2014). Gone to Pot - A Review of the Association between Cannabis and Psychosis. Frontiers in psychiatry. 5: 54-78.

Radwan M. M., Chandra S., Gul S., and ElSohly M. A. (2021). Cannabinoids, Phenolics, Terpenes and Alkaloids of Cannabis. Molecules. 26(9): 2774-2803.

Rasera G. B., Ohara A. and Soares de Castro R. J. (2021). Innovative and emerging applications of cannabis in food and beverage products: From an illicit drug to a potential ingredient for health promotion. Food Science & Technology. 115: 31-41.

Russo E. B. (2011). Taming THC: potential cannabis synergy and phytocannabinoid-terpenoid entourage effects. British journal of pharmacology. 163(7): 1344–1364.

Schwab U. S., Callaway J. C., Erkkilä A. T., Gynther J., Uusitupa M. I. and Järvinen T. (2006). Effects of hempseed and flaxseed oils on the profile of serum lipids, serum total and lipoprotein lipid concentrations and haemostatic factors. European journal of nutrition. 45(8): 470–477.

Sharma P., Murthy P. and Bharath M. M. (2012). Chemistry, metabolism, and toxicology of cannabis: clinical implications. Iranian journal of psychiatry. 7(4): 149–156.

Singh A., Saluja S., Kumar A., Agrawal S., Thind M. and Nanda S. (2018). Cardiovascular Complications of Marijuana and Related Substances: A Review. Cardiology and therapy. 7(1): 45–59.

Tait M. A., Costa D., Campbell R., Norman R., Schug S. and Rutherford, C. (2021). A Quality-of-Life Evaluation Study Assessing Health-Related Quality of Life in Patients Receiving Medicinal Cannabis (the QUEST Initiative): Protocol for a Longitudinal Observational Study. JMIR research protocols. 10(11): 323-327.

Ujváry I and Hanuš L. Human Metabolites of Cannabidiol: A Review on Their Formation, Biological Activity, and Relevance in Therapy. Cannabis Cannabinoid Res. 1(1):90-101.

United Nations. (1961). Single Convention on Narcotic Drugs. Retrieved June 14, 2022, from convention_1961_ en.pdf

Vladimir‐Knežević S., Blažeković B., and Kindl M. B. Š. a. (2017). Phytochemical Aspects and Therapeutic Perspective of Cannabinoids in Cancer Treatment. Retrieved June 14, 2022, from /54967.

Zendulka O., Dovrtělová G., Nosková K., Turjap M., Šulcová A., Hanuš L., and Juřica, J. (2016). Cannabinoids and Cytochrome P450 Interactions. Current drug metabolism. 17(3): 206–226.